CytomX Therapeutics Announces Milestone Achievement in Strategic Collaboration with Regeneron in the Field of Conditionally Activated Bispecifics
- CytomX to receive $5 million preclinical milestone payment -
- CytomX to receive $5 million preclinical milestone payment -